Thomas Neal J, Carcillo Joseph A, Doughty Lesley A, Sasser Howell, Heine R Phillip
Department of Anesthesiology and Critical Care Medicine, University of Pittsburgh School of Medicine and Children's Hospital of Pittsburgh, Pittsburgh, PA 15213, USA.
Pediatr Infect Dis J. 2002 Jan;21(1):34-8. doi: 10.1097/00006454-200201000-00008.
We hypothesized that systemic release of endogenous leukocyte-derived polypeptide antimicrobial defensins (polymorphonuclear leukocyte-specific) and lactoferrin (polymorphonuclear leukocyte and epithelial cell derived) occurs in nonneutropenic children with severe sepsis.
We performed a prospective cross-sectional and longitudinal study in a university children's hospital pediatric intensive care unit. Ninety-two consecutive children meeting criteria for sepsis and 14 critically ill children without sepsis (controls) were enrolled, and plasma defensins and lactoferrin concentrations were measured on Days 1 and 3 of sepsis.
Nonneutropenic sepsis patients (n = 71) had increased defensins and lactoferrin plasma concentrations compared with critically ill control patients [defensins, 450 ng/ml vs. 150 ng/ml; lactoferrin, 332 ng/ml vs. 176 ng/ml (median values); P < 0.05] and neutropenic sepsis patients [n = 21; defensins, 450 ng/ml vs. 50 ng/ml; lactoferrin, 332 ng/ml vs. 20 ng/ml (median values); P < 0.05]. Neutropenic sepsis patients had similar plasma defensin concentrations and a decrease in plasma lactoferrin concentrations compared with control patients (P < 0.05). Defensins and lactoferrin plasma concentrations correlated to total white blood cell and absolute neutrophil count (P < 0.05). There was no association between plasma defensin concentration and organ failure or outcome; however, increased plasma lactoferrin concentrations were observed with the development of organ failure (P < 0.05).
These data suggest that increased circulating defensins and lactoferrin release are dependent in part on neutrophil count and might play a role in host defense in children with severe sepsis.
我们推测,在非中性粒细胞减少的重症脓毒症患儿中,会出现内源性白细胞衍生的多肽抗菌防御素(多形核白细胞特异性)和乳铁蛋白(多形核白细胞和上皮细胞衍生)的全身释放。
我们在一家大学儿童医院的儿科重症监护病房进行了一项前瞻性横断面和纵向研究。连续纳入了92名符合脓毒症标准的儿童和14名无脓毒症的危重症儿童(对照组),并在脓毒症第1天和第3天测量血浆防御素和乳铁蛋白浓度。
与危重症对照患者相比,非中性粒细胞减少的脓毒症患者(n = 71)血浆防御素和乳铁蛋白浓度升高[防御素,450 ng/ml对150 ng/ml;乳铁蛋白,332 ng/ml对176 ng/ml(中位数);P < 0.05],与中性粒细胞减少的脓毒症患者相比也是如此[n = 21;防御素,450 ng/ml对50 ng/ml;乳铁蛋白,332 ng/ml对20 ng/ml(中位数);P < 0.05]。与对照患者相比,中性粒细胞减少的脓毒症患者血浆防御素浓度相似,血浆乳铁蛋白浓度降低(P < 0.05)。血浆防御素和乳铁蛋白浓度与总白细胞计数和绝对中性粒细胞计数相关(P < 0.05)。血浆防御素浓度与器官衰竭或预后之间无关联;然而,随着器官衰竭的发生,观察到血浆乳铁蛋白浓度升高(P < 0.05)。
这些数据表明,循环防御素和乳铁蛋白释放增加部分取决于中性粒细胞计数,可能在重症脓毒症患儿的宿主防御中发挥作用。